logo

Neos Therapeutics, Inc. (NEOS)



Trade NEOS now with
  Date
  Headline
3/12/2021 9:06:27 AM Glass Lewis Recommends Neos Therapeutics Stockholders Vote For Pending Merger With Aytu BioScience
9/4/2015 9:09:05 AM RBC Capital Markets Is Cutting Neos Therapeutics, Inc. (NEOS) FY16 Estimate To -3.74 From -3.68
9/4/2015 9:08:45 AM RBC Capital Markets Is Lowering Neos Therapeutics, Inc. (NEOS) FY15 Estimate To -12.32 From -7.90
9/4/2015 9:08:22 AM RBC Capital Markets Is Lowering Neos Therapeutics, Inc. (NEOS) Q4 16 Estimate To -0.81 From -0.79
9/4/2015 9:08:02 AM RBC Capital Markets Is Lowering Neos Therapeutics, Inc. (NEOS) Q3 16 Estimate To -1.09 From -1.06
8/17/2015 9:14:48 AM RBC Capital Markets Initiates Neos Therapeutics, Inc. (NEOS) At Outperform With $35 Price Target